ED
53
-5
EMN
70
-2
ES
55
-5
HRL
38
2
CI
66
-2
TGT
50
2
BWA
42
-2
BAC
39
-2
SO
64
-2
SHW
71
-2
COST
51
-3
NWL
32
-3
PLD
51
-5
NSC
62
2
CNX
76
5
MCHP
42
-5
M
14
2
DVN
35
2
DTE
56
-7
AMGN
55
-2
ED
53
-5
EMN
70
-2
ES
55
-5
HRL
38
2
CI
66
-2
TGT
50
2
BWA
42
-2
BAC
39
-2
SO
64
-2
SHW
71
-2
COST
51
-3
NWL
32
-3
PLD
51
-5
NSC
62
2
CNX
76
5
MCHP
42
-5
M
14
2
DVN
35
2
DTE
56
-7
AMGN
55
-2
Financhill
Back

Fulcrum Therapeutics 10K Form

Sell
1

FULC
Fulcrum Therapeutics

Last Price:
3.54
Seasonality Move:
-0.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive FULC News And Ratings

See the #1 stock for the next 7 days that we like better than FULC

FULC Financial Statistics

Sales & Book Value

Annual Sales: $2.81M
Cash Flow: $58.9M
Price / Cash Flow: 0
Annual Sales: $4.40
Price / Book: 0.78

Profitability

EPS (TTM): -0.35000
Net Income (TTM): $-20.23M
Gross Margin: --
Return on Equity: -8.07%
Return on Assets: -7.42%

Fulcrum Therapeutics Earnings Forecast

Key Fulcrum Therapeutics Financial Ratios

  • The Research & Development expenses have been 2,559.75% of Revenue.
  • The Net Earning history of FULC is -3,470.05% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 4 years.

Fulcrum Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: FULC
CUSIP: 359616
Website: fulcrumtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 22.07
Quick Ratio: 21.84

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

FULC Technical Analysis vs Fundamental Analysis

Sell
1
Fulcrum Therapeutics (FULC) is a Sell

Is Fulcrum Therapeutics a Buy or a Sell?